z-logo
open-access-imgOpen Access
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
Author(s) -
ByeongKeuk Kim,
SungJin Hong,
YunHyeong Cho,
Kyeong Ho Yun,
Yong Hoon Kim,
Yongsung Suh,
Jae Young Cho,
AeYoung Her,
Sungsoo Cho,
Dong Woon Jeon,
SangYong Yoo,
DeokKyu Cho,
BumKee Hong,
Hyuck Moon Kwon,
ChulMin Ahn,
DongHo Shin,
Chung Mo Nam,
JungSun Kim,
YoungGuk Ko,
Donghoon Choi,
MyeongKi Hong,
Yangsoo Jang
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.7580
Subject(s) - ticagrelor , medicine , acute coronary syndrome , aspirin , myocardial infarction , cardiology , stroke (engine) , adverse effect , randomized controlled trial , mechanical engineering , engineering
Discontinuing aspirin after short-term dual antiplatelet therapy (DAPT) was evaluated as a bleeding reduction strategy. However, the strategy of ticagrelor monotherapy has not been exclusively evaluated in patients with acute coronary syndromes (ACS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom